Releases
Park Ha Biological Technology Faces Class Action Over Stock Manipulation
A federal class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd., alleging the firm misled investors through a fraudulent stock promotion scheme. The complaint claims the company failed to disclose artificial trading activity and misinformation campaigns that inflated its stock price during the first half of 2025.





















